Skip to content
value.today

Omada Health, Inc.

Total raised
$72 M
2 rounds on record
Latest round
$49 M
Jul 2015
First round on record
Apr 2014
Today
Went public
See the company page

Omada Health, Inc. is listed today as Omada Health, Inc.: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Omada Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2015$49 MNo. 2$10 to $50 million

Omada Health, Inc.: Raise no. 2, Jul 2015

Investors in this round

16 investors had bought by the notice of Oct 1, 2015: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Omada Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$49 M of $49 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series C Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adrian James · Executive Officer, Director
  • Andrew DiMichelle · Executive Officer, Director
  • Sean Duffy · Executive Officer, Director
  • Balaji Srinivasan · Director
  • Casper De Clercq · Director
  • Jonathan Root · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sean Duffy, Ceo. Newest notice filed Oct 1, 2015. Read the notice at the SEC.

equitySEC
Apr 2014$23 MNo. 1$10 to $50 million

Omada Health, Inc.: Raise no. 1, Apr 2014

Investors in this round

12 investors had bought by the notice of Jun 20, 2014: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Omada Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$23 M of $23 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series B Preferred Stock and Common Stock issuable upon conversion
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adrian James · Executive Officer, Director
  • Andrew DiMichelle · Executive Officer
  • Sean Duffy · Executive Officer, Director
  • Jonathan Root · Director
  • Tony Chou · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sean Duffy, Ceo. Newest notice filed Jun 20, 2014. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Omada Health, Inc., its revenue in fiscal 2025 came from these product and service lines: Hardware $19.17 million (7%).

    Annual report (SEC XBRL) · Dec 2025

  • Omada Health, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2015).

    SEC Form D · Oct 2015

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Oct 2015

Products and services#

No products or services of Omada Health, Inc. are on record.

Investors#

9 named in official filings. Open an investor to see everything it has backed.

Investors in Omada Health, Inc.
InvestorKindAmountRoundRoleSource
Revelation Alpine GP, LLCOthernot statednot statedHeld Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Revelation Alpine, LLCOthernot statednot statedHeld Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Revelation Alpine, L.P.Fund or asset managernot statednot statedHeld Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Revelation Healthcare Fund II GP, LLCFund or asset managernot statednot statedHeld Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Revelation Healthcare Fund II GP, L.P.Fund or asset managernot statednot statedHeld Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Revelation Healthcare Fund II, L.P.Fund or asset managernot statednot statedHeld Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Revelation Healthcare Fund IV GP, LLCFund or asset managernot statednot statedHeld Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Revelation Healthcare Fund IV GP, L.P.Fund or asset managernot statednot statedHeld Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Revelation Healthcare Fund IV, L.P.Fund or asset managernot statednot statedHeld Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025)SEC Form 3

Largest shareholders today

Institutions holding Omada Health, Inc. shares, as of Sep 30, 2026.

As of Sep 30, 2026

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Omada Health, Inc.
NameRoleNamed in
Adrian JamesExecutive officerOct 2015
Andrew DiMichelleExecutive officerOct 2015
Sean DuffyExecutive officerOct 2015
Adrian JamesDirectorOct 2015
Andrew DiMichelleDirectorOct 2015
Balaji SrinivasanDirectorOct 2015
Casper De ClercqDirectorOct 2015
Jonathan RootDirectorOct 2015
Sean DuffyDirectorOct 2015
Tony ChouDirectorJun 2014

Went public since 2025. Its SEC number is that of a company listed on a stock exchange.